Meridian Biosciences (VIVO) added to STI Medical Profits Portfolio
For the reasons described in the 6/29/2015 edition of Smart Tech 50 Weekly Movers, we are adding Meridian Biosciences (VIVO) to the Medical Profits portfolio with a buy limit price of $19 and a stop loss at $16.
Stock Talk
Add New Comments
You must be logged in to post to Stock Talk OR create an account